07:57 AM EDT, 10/21/2024 (MT Newswires) -- AbbVie's ( ABBV ) Allergan Aesthetics unit said Monday the US Food and Drug Administration has approved its Botox Cosmetic brand of onabotulinumtoxinA to treat adult patients with moderate to severe platysma bands.

Platysma bands connect the jaw and neck, and the cosmetic treatment is intended to improve the appearance of moderate to severe bands, AbbVie ( ABBV ) said.

The biopharmaceutical company said its onabotulinumtoxinA brand Botox Cosmetic has already been approved to treat forehead lines, frown lines, and crow's feet lines, making the approval for use on the platysma bands the 'first product of its kind to go beyond the face.'

Price: 188.88, Change: +0.02, Percent Change: +0.01